|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-6-2
|
|
pubmed:abstractText |
MAVERIC was a randomised clinical trial designed to test the possibility of prospectively identifying patients who would benefit most from the implantable cardioverter-defibrillator (ICD) by electrophysiology (EP) study in the context of secondary prevention of sudden cardiac death (SCD) through comparing EP-guided interventions (anti-arrhythmic drugs, coronary revascularization, and ICD) against empirical amiodarone therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1099-5129
|
|
pubmed:author |
pubmed-author:CluneM MMM,
pubmed-author:CooperJJ,
pubmed-author:FoschiA EAE,
pubmed-author:GarrattC JCJ,
pubmed-author:GrayR GRG,
pubmed-author:GriffithM JMJ,
pubmed-author:LauE WEW,
pubmed-author:MarshallH JHJ,
pubmed-author:NiG CGC,
pubmed-author:PathmanathanR KRK,
pubmed-author:SkehanJ DJD,
pubmed-author:StaffordP JPJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
257-66
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15172648-Amiodarone,
pubmed-meshheading:15172648-Anti-Arrhythmia Agents,
pubmed-meshheading:15172648-Clinical Protocols,
pubmed-meshheading:15172648-Death, Sudden, Cardiac,
pubmed-meshheading:15172648-Defibrillators, Implantable,
pubmed-meshheading:15172648-Electrocardiography, Ambulatory,
pubmed-meshheading:15172648-Electrophysiologic Techniques, Cardiac,
pubmed-meshheading:15172648-Humans,
pubmed-meshheading:15172648-Multivariate Analysis,
pubmed-meshheading:15172648-Prospective Studies,
pubmed-meshheading:15172648-Risk Assessment,
pubmed-meshheading:15172648-Survival Analysis,
pubmed-meshheading:15172648-Tachycardia, Ventricular
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
|
|
pubmed:affiliation |
Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
